Critical Care Reviews Podcast
REMAP-CAP Trial Long Term Outcomes
Mar 13, 2024
Dr. Lisa Higgins presents long-term outcomes of REMAP-CAP trial at Critical Care Reviews Meeting 2023. Prof. Christopher Seymour explores 180-day outcomes for pandemic patients. Analysis includes treatments like antivirals, corticosteroids, and anticoagulants. Challenges in post-ICU follow-up and successes of platforms like Remap Cap discussed.
47:09
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- REMAP-CAP trial examined long-term outcomes of COVID-19 treatments on ICU patients.
- Study showed variations in survivor outcomes with different treatments for COVID-19 patients.
Deep dives
Overview of Remap-Cap Presentation
The Remap-Cap presentation discusses a follow-up paper on pandemic patients from the Remap-Cap trials led by Dr. Lisa Higgins. The trial's design as a platform trial allowed for simultaneous study of various treatments for COVID-19. The focus was on critically ill patients, with randomization to different treatment domains. Results from six domains were published, showing varied outcomes such as benefit, harm, or no effect.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
